Gaurav Bhaduka, Jitendra Singh Rajawat
Gaurav Bhaduka1*, Jitendra Singh Rajawat2
1Research Scholar, Faculty of Pharmacy, Bhupal Nobles' University, Maharana Pratap Station Road, Sevashram Circle, Udaipur-313001, Rajasthan, India.
2Assistant Professor, Faculty of Pharmacy, Bhupal Nobles' University, Maharana Pratap Station Road, Sevashram Circle, Udaipur-313001, Rajasthan, India.
Volume - 13,
Issue - 10,
Year - 2020
The objective of the present investigation was to formulation development of solid dispersion of voriconazole using hot-melt, solvent evaporation and combination of these two methods together with Gelucire® 44/14, polaxamer 188 and polyvinyl pyrrolidone (PVP) K30 and the different characteristics like drug content analysis and in vitro release of the solid dispersions were investigated. The drug-carriers compatibility of the solid dispersions were investigated by Fourier transform infra-red spectroscopy (FTIR) and differential scanning calorimetry (DSC) study and crystal characteristic of solid dispersions were evaluated by X-ray diffraction (XRD) study. The in vitro release study revealed that among all the physical mixtures and solid dispersions prepared by using different carriers, solid dispersions that contained Gelucire® 44/14 and Poloxamer 188 as carrier in the ratio of 1:5 (voriconazole: carrier) were released voriconazole in simulated gastric fluid within short period of time. The FTIR spectrum and DSC thermograms indicated the compatibility of drug and carriers. The diffusion exponent (n) determined from in vitro release data of solid dispersions FCG5 and FCP5 were found 0.391 and 0.325, respectively, indicating Fickian drug release mechanism.
Cite this article:
Gaurav Bhaduka, Jitendra Singh Rajawat. Formulation Development and Solubility Enhancement of Voriconazole by Solid Dispersion Technique. Research J. Pharm. and Tech. 2020; 13(10):4557-4564. doi: 10.5958/0974-360X.2020.00803.3
1. Bikiaris DN. Solid dispersions, Part I: Recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs. Expert Opin. Drug Deliv. 2011; 8:1501–1519.
2. Bikiaris DN. Solid dispersions, Part II: New strategies in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs. Expert Opin. Drug Deliv. 2011; 8:1663–1680.
3. Srinivas P, Sreeja K. Formulation and evaluation of voriconazole loaded nanosponges for oral and topical delivery. Int. J. Drug Dev. Res. 2013; 5(1):55-69.
4. Sanati H, Belanger P, Fratti R, Ghannoum M. A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei. Antimicrob. Agents Chemother. 1997; 41: 2492–2496.
5. Kumar SS, Thakuria R, Nangia A. Pharmaceutical cocrystals and a nitrate salt of voriconazole. Cryst Eng Comm. 2014; 16: 282.
6. Khare A, Singh I, Pawar P, Grover K. Design and evaluation of voriconazole loaded solid lipid nanoparticles for ophthalmic application. Journal of Drug Delivery. 2016; Article ID 6590361.
7. Siafaka PI, Okur NÜO, Mone M, Giannakopoulou S, Er S, Pavlidou E, Karavas E, Bikiaris D. Two different approaches for oral administration of voriconazole loaded formulations: electrospun fibers versus β-cyclodextrin complexes. Int J Mol Sci. 2016; 17(3): 282.
8. Higuchi T, Connors KA. Phase solubility techniques. Adv. Anal. Chem. Instrum. 1965; 4:117–212.
9. Chowdhary KP, Rao SS. Dissolution rate and formulation studies on solid dispersion of Itraconazole. Indian Journal of Pharmaceutical Sciences. 2000; 62(6):471-4.
10. Patel R. Physic-chemical characterization and dissolution study of solid dispersion of Furosemide with PEG 6000 and PVP K (30). 2010; 2: 17-25.
11. Kaur LK, Kumar SA, Solid dispersions: A Promising approach for improving dissolution characteristics of a poorly soluble drug, IJPRR, 3, 2011, 1-7.
12. Maheshwari RK, Jawade S, Fouzdar A. Formulation Development of Aqueous Injection of Poorly Soluble Drug Using Mixed Hydrotropic Solubilization Concept and Its Evaluation, International Journal of Pharmaceutical Sciences and Drug Research 2015; 7 (1): 8-12.
13. Murali Mohan Babu GV, Prasad CHDS, Ramana Murthy KV. Evaluation of modified gum karaya as carrier for the dissolution enhancement of poorly water-soluble drug nimodipine. Int J Pharm. 2002; 234:1Y17. 7.
14. Murray MD., Haag KM., Black PK., Hall SD., Brater DC., Variable furosemide absorption and poor predictability of response in elderly patient. Pharmacotherapy. 1997; 17, 98 – 106.
15. K. Sekiguchi, Obi N. Studies on absorption of eutectic mixtures. I. A comparison of the behaviour of eutectic mixtures of sulphathiazole and that of ordinary sulphathiazole in man, Chem. Pharm. Bull 1961; 9: 866-872.
16. Chiou WL, Riegelman S. Pharmaceutical Applications of Solid Dispersion Systems. J Pharm Sci 1971; 60: 1281-1302.
17. Vasconceleos T, et al. Solid Dispersion as Strategy to Improve Oral bioavailability of poor Water-Soluble Drugs. Drug Dis Today 2007; 12: 1068-1075.
18. Ghosh TK, Pfister WR, Quick dissolving oral dosage forms: Scientific and regulatory considerations from a clinical pharmacology and biopharmaceuticals perspective; In: Drug delivery to the oral cavity: Molecules to market, New York, CRC Press, 2005,337-356.
19. Tiwari RU, Rai AK, Solid dispersions: An overview to modify bioavailability of poorly water-soluble drugs, IJPR, 4, 2009, 1338-1349.
20. Kate BA, Phulzalke SB, Deshmukh MT, Solubility Enhancement of Poorly Water-Soluble Drug Zaltoprofen by Mixed Hydrotropy Approach. Asian journal of Biomedical and Pharmaceutical Sciences. 2016; 6(57): 32-39.